In order to elucidate the blocking effect of Gynostemma pentaphyllum Makino (GP), one of the Chinese medicines, on the point mutation of Ha-ras, oral leukoplakia (OLP) induced by dimethylbenzanthracene (DMBA) in the cheek pouch of Syrian hamster was used. GP was taken in the hamsters with OL. Using the polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) technique and tissue specimens indicating OL, the point mutation of Ha-ras oncogene on codon 61 was investigated. The incidences of point mutation were 22.92% in GP-untreated OL and 7.52% in GP-treated OL (6.25% in the glucoside group, 11.00% in the aglucon group and 5.32% in the C20-OH group). GP might prevent the point mutation of Ha-ras oncogene related to OL canceration. This study also suggests that the hydroxyl ion may be the potent component of GP in the inhibition of canceration.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2000) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: